- Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results Merck
- Merck beats estimates on fourth-quarter on earnings—but stock slides pre-market on tepid 2025 guidance Yahoo Finance
- Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine shipments to China CNBC
- Merck Stock Tumbles on Weak Guidance and Gardasil Sales Slump Barron’s
- Merck temporarily pauses Gardasil shipments to China following sales slowdown Endpoints News